共 50 条
- [3] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
- [6] Symptom burden of patients with moderate-to-severe atopic dermatitis European Journal of Dermatology, 2021, 31 : 752 - 758
- [8] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300